Literature DB >> 17338550

Differentiation of secreted and membrane-type matrix metalloproteinase activities based on substitutions and interruptions of triple-helical sequences.

Dmitriy Minond1, Janelle L Lauer-Fields, Mare Cudic, Christopher M Overall, Duanqing Pei, Keith Brew, Marcia L Moss, Gregg B Fields.   

Abstract

The turnover of the collagen triple-helical structure (collagenolysis) is a tightly regulated process in normal physiology and has been ascribed to a small number of proteases. Several members of the matrix metalloproteinase (MMPs) family possess collagenolytic activity, and the mechanisms by which these enzymes process triple helices are beginning to be unraveled. The present study has utilized two triple-helical sequences to compare the cleavage-site specificities of 10 MMPs. One substrate featured a continuous Gly-Xxx-Yyy sequence (Pro-Leu-Gly approximately Met-Arg-Gly), while the other incorporated an interruption in the Gly-Xxx-Yyy repeat (Pro-Val-Asn approximately Phe-Arg-Gly). Both sequences were selectively cleaved by MMP-13 while in linear form, but neither proved to be selective within a triple helix. This suggests that the conformational presentation of substrate sequences to a MMP active site is critical for enzyme specificity, in that activities differ when sequences are presented from an unwound triple helix versus an independent single strand. Differences in specificity between secreted and membrane-type (MT) MMPs were also observed for both sequences, where MMP-2 and MT-MMPs showed an ability to hydrolyze a triple helix at an additional site (Gly-Gln bond). Interruption of the triple helix had different effects on secreted MMPs and MT-MMPs, because MT-MMPs could not hydrolyze the Asn-Phe bond but instead cleaved the triple helix closer to the C terminus at a Gly-Gln bond. It is possible that MT-MMPs have a requirement for Gly in the P1 subsite to be able to efficiently process a triple-helical molecule. Analysis of individual kinetic parameters and activation energies indicated different substrate preferences within secreted MMPs, because MMP-13 preferred the interrupted sequence, while MMP-8 showed little discrimination between non-interrupted and interrupted triple helices. On the basis of the present and prior studies, we can assign unique triple-helical peptidase behaviors to the collagenolytic MMPs. Such differences may be significant for understanding MMP mechanisms of action and aid in the development of selective MMP inhibitors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17338550      PMCID: PMC2569894          DOI: 10.1021/bi062199j

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  68 in total

1.  Animal collagenases: specificity of action, and structures of the substrate cleavage site.

Authors:  J Gross; E Harper; E D Harris; P A McCroskery; J H Highberger; C Corbett; A H Kang
Journal:  Biochem Biophys Res Commun       Date:  1974-11-27       Impact factor: 3.575

2.  Cleavage of Type II and III collagens with mammalian collagenase: site of cleavage and primary structure at the NH2-terminal portion of the smaller fragment released from both collagens.

Authors:  E J Miller; E D Harris; E Chung; J E Finch; P A McCroskery; W T Butler
Journal:  Biochemistry       Date:  1976-02-24       Impact factor: 3.162

Review 3.  Triple-helical peptide analysis of collagenolytic protease activity.

Authors:  Janelle L Lauer-Fields; Gregg B Fields
Journal:  Biol Chem       Date:  2002 Jul-Aug       Impact factor: 3.915

4.  Selective hydrolysis of triple-helical substrates by matrix metalloproteinase-2 and -9.

Authors:  Janelle L Lauer-Fields; Thilaka Sritharan; M Sharon Stack; Hideaki Nagase; Gregg B Fields
Journal:  J Biol Chem       Date:  2003-03-17       Impact factor: 5.157

5.  Identification of peptide substrates for human MMP-11 (stromelysin-3) using phage display.

Authors:  Weijun Pan; Marc Arnone; Marvin Kendall; Robert H Grafstrom; Steven P Seitz; Zelda R Wasserman; Charles F Albright
Journal:  J Biol Chem       Date:  2003-05-08       Impact factor: 5.157

6.  Collagenase unwinds triple-helical collagen prior to peptide bond hydrolysis.

Authors:  Linda Chung; Deendayal Dinakarpandian; Naoto Yoshida; Janelle L Lauer-Fields; Gregg B Fields; Robert Visse; Hideaki Nagase
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

7.  Characterization of the distinct collagen binding, helicase and cleavage mechanisms of matrix metalloproteinase 2 and 14 (gelatinase A and MT1-MMP): the differential roles of the MMP hemopexin c domains and the MMP-2 fibronectin type II modules in collagen triple helicase activities.

Authors:  Eric M Tam; Todd R Moore; Georgina S Butler; Christopher M Overall
Journal:  J Biol Chem       Date:  2004-08-02       Impact factor: 5.157

8.  Matrix metalloproteinase triple-helical peptidase activities are differentially regulated by substrate stability.

Authors:  Dmitriy Minond; Janelle L Lauer-Fields; Hideaki Nagase; Gregg B Fields
Journal:  Biochemistry       Date:  2004-09-14       Impact factor: 3.162

9.  A proteomic approach to identify substrates of matrix metalloproteinase-14 in human plasma.

Authors:  In Kwan Hwang; Sung Min Park; Se Yeon Kim; Seung-Taek Lee
Journal:  Biochim Biophys Acta       Date:  2004-10-01

10.  Analysis of matrix metalloproteinase triple-helical peptidase activity with substrates incorporating fluorogenic L- or D-amino acids.

Authors:  Janelle L Lauer-Fields; Péter Kele; Guodong Sui; Hideaki Nagase; Roger M Leblanc; Gregg B Fields
Journal:  Anal Biochem       Date:  2003-10-01       Impact factor: 3.365

View more
  29 in total

1.  Using fluorogenic peptide substrates to assay matrix metalloproteinases.

Authors:  G B Fields
Journal:  Methods Mol Biol       Date:  2001

2.  Comparison of metalloproteinase protein and activity profiling.

Authors:  Orsi Giricz; Janelle L Lauer; Gregg B Fields
Journal:  Anal Biochem       Date:  2010-10-23       Impact factor: 3.365

3.  Conformational dynamics accompanying the proteolytic degradation of trimeric collagen I by collagenases.

Authors:  Arjun S Adhikari; Emerson Glassey; Alexander R Dunn
Journal:  J Am Chem Soc       Date:  2012-08-01       Impact factor: 15.419

4.  Examination of matrix metalloproteinase-1 in solution: a preference for the pre-collagenolysis state.

Authors:  Linda Cerofolini; Gregg B Fields; Marco Fragai; Carlos F G C Geraldes; Claudio Luchinat; Giacomo Parigi; Enrico Ravera; Dmitri I Svergun; João M C Teixeira
Journal:  J Biol Chem       Date:  2013-09-11       Impact factor: 5.157

5.  Matrix metalloproteinase inhibition by heterotrimeric triple-helical Peptide transition state analogues.

Authors:  Manishabrata Bhowmick; Roma Stawikowska; Dorota Tokmina-Roszyk; Gregg B Fields
Journal:  Chembiochem       Date:  2015-03-12       Impact factor: 3.164

6.  Tricine as a convenient scaffold for the synthesis of C-terminally branched collagen-model peptides.

Authors:  Maciej J Stawikowski; Gregg B Fields
Journal:  Tetrahedron Lett       Date:  2017-12-05       Impact factor: 2.415

7.  Microwave-assisted synthesis of triple-helical, collagen-mimetic lipopeptides.

Authors:  Jayati Banerjee; Andrea J Hanson; Wallace W Muhonen; John B Shabb; Sanku Mallik
Journal:  Nat Protoc       Date:  2009-12-17       Impact factor: 13.491

8.  Direct visualization of protease action on collagen triple helical structure.

Authors:  Gabriel Rosenblum; Philippe E Van den Steen; Sidney R Cohen; Arkady Bitler; David D Brand; Ghislain Opdenakker; Irit Sagi
Journal:  PLoS One       Date:  2010-06-16       Impact factor: 3.240

9.  The synthesis and application of Fmoc-Lys(5-Fam) building blocks.

Authors:  Michal Tokmina-Roszyk; Dorota Tokmina-Roszyk; Gregg B Fields
Journal:  Biopolymers       Date:  2013-07       Impact factor: 2.505

10.  The role of collagen charge clusters in the modulation of matrix metalloproteinase activity.

Authors:  Janelle L Lauer; Manishabrata Bhowmick; Dorota Tokmina-Roszyk; Yan Lin; Steven R Van Doren; Gregg B Fields
Journal:  J Biol Chem       Date:  2013-12-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.